期刊文献+

长时间卧床住院患者下肢深静脉血栓形成的相关因素病例对照研究 被引量:21

Analysis of Risk Factors of Lower Extremity Deep Venous Thrombosis in Prolonged Bed Rest Inpatients
下载PDF
导出
摘要 目的探讨长时间卧床住院患者下肢深静脉血栓形成(DVT)的相关因素。方法采用病例对照研究。选取2007年6月—2009年6月住院绝对卧床时间1周以上确诊为下肢DVT的患者83例作为病例组,同期住院绝对卧床1周以上但未发生下肢DVT的患者111例作为对照组。收集相关临床资料,分析各因素与下肢DVT的关系。结果两组患者的性别构成、体质指数、住院天数、绝对卧床天数比较,差异均无统计学意义(P>0.05);但病例组患者的年龄低于对照组、吸烟率高于对照组,差异均有统计学意义(P<0.05)。两组患者的手术史、创伤史、心血管疾病史比较,差异均有统计学意义(P<0.05);而两组患者的其他疾病史比较,差异均无统计学意义(P>0.05)。病例组患者的抗血小板药物、抗凝药物及活血化瘀药物的使用率低于对照组,差异均有统计学意义(P<0.01)。病例组高纤维蛋白原血症检出率高于对照组,差异有统计学意义(P=0.000)。多因素Logistic回归分析结果显示,高纤维蛋白原血症〔OR=12.700,95%CI(1.946,82.894),P=0.008〕是住院患者下肢DVT的独立危险因素;而抗血小板药物〔OR=0.031,95%CI(0.004,0.247),P=0.001〕、抗凝药物〔OR=0.059,95%CI(0.005,0.690),P=0.024〕、活血化瘀药物〔OR=0.005,95%CI(0.001,0.046),P=0.000〕是其保护因素。结论高纤维蛋白原血症是住院长时间卧床患者下肢DVT的独立危险因素,长期卧床患者应注意降纤治疗。抗血小板药物、抗凝药物、活血化瘀药物的应用可减少住院患者下肢DVT的发生。 Objective To investigate risk factors of lower extremity deep venous thrombosis (DVT) for the inpatients with long stay in bed and to detect preventive measures. Methods Case control studies were performed. The patients (83 cases) from the First Hospital of Qinhuangdao City (June 2007 to June 2009) who have been absolutely in bed rest for more than one week and diagnosed as DVT were enrolled as case group, while those (111 cases) who absolutely in bed rest over one week but not diagnosed as DVT were involved as control group. Related data were collected and the correlation between each factor and DVT was analyzed. Results The gender composition, BMI, hospital stay and absolute bed rest days between the two groups showed no statistically significant difference ( P 〉 0.05 ). The age of the case group was significantly younger than the control group and the smoking rate of the case group was significantly higher than the control group ( P 〈 0. 05 ). The operation history, trauma history and CVD history between the two groups showed statistically significant differences ( P 〈 0.05 ), while other dis- ease history showed no statistically significant difference between the two groups ( P 〉 0. 05 ). The application rate of anti - plate- let agents, anti - coagulant drugs and medicines for promoting blood circulation and removing blood stasis in the case group was significantly lower than those of the control group ( P 〈 0. 01 ). The detection rate of hyperfibrinogenemia in the case group was significantly higher than in the control group ( P = 0. 000). The multi - factor logistic regression analysis showed that hyperfibrinogenemia was an independent risk factor for DVT [ OR = 12. 700, 95 % CI (1. 946, 82. 894), P = 0. 008 ], while anti -platelet agents (OR=0.031, 95% CI (0.004, 0.247), P =0.0011, anti - coagulant drugs (OR =0.059, 95% CI (0.005, 0. 690) , P =0. 024] and medicines for promoting blood circulation and removing blood stasis [ OR =0. 005, 95% CI (0. 001,0. 046), P = 0. 000 ] were protective factors. Conclusion Hyperfibrinogenemia is an independent risk factor for DVT among long bed rest patients, so fibrinolytic treatment should be paid more attention to. Antiplatelet and anticoagulant therapy and medicines for promoting blood circulation and removing blood stasis can reduce the incidence of DVT in hospitalized patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第30期3466-3469,共4页 Chinese General Practice
关键词 深静脉血栓形成 住院 长时间卧床 危险因素 Deep vein thrombosis Inpatients Long bed Risk factors
  • 相关文献

参考文献10

  • 1Shorr AF, Jackson WL, Sherner JH, et al. Differences between low - molecular - weight and unfractionated heparin for venous thromboembolism prevention following ischemie stroke : a metaanalysis [ J ]. Chest, 2008, 133 (1): 149-155.
  • 2Van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are ssociated with the risk of deep venous thrombosis mainly in the elderly [J]. J Thromb Haemost, 2003, 1 (12) : 2677 -2678.
  • 3White RH. The epidemiology of venous thromboembolism [ J ]. Circulation, 2003, 107 (23 Suppl 1): 4-8.
  • 4Syed FF, Beeching NJ. Lower - limb deep - vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous druguse [J]. QJM, 2005, 98 (2) 139-145.
  • 5Sarmiento A, Goswami AD. Thrombocmbolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty [ J ]. J Bone Joint Surg Am, 1999, 81 (3) : 339 -346.
  • 6陈新谦 金有豫 汤光.新编药物学[M].北京:人民卫生出版社,2004.462.
  • 7崔峰.下肢深静脉血栓形成早期低分子肝素治疗的安全性评价[J].中国现代医药杂志,2007,9(12):68-70. 被引量:22
  • 8马长生.心房颤动抗栓药物治疗进展[J].临床药物治疗杂志,2011,9(3):1-5. 被引量:11
  • 9王斯闻,朱杰,张汝新,王霞,王楠,姚凤臣.丹参川芎嗪对不稳定型心绞痛患者血脂影响及临床疗效[J].中国医学工程,2011,19(5):1-3. 被引量:8
  • 10郭宏杰,张宪生.疏血通注射液对凝血功能的影响[J].中国现代医学杂志,2007,17(19):2380-2382. 被引量:15

二级参考文献52

共引文献184

同被引文献283

引证文献21

二级引证文献250

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部